Login or sign up
For business

Bukwang Pharmaceutical Co

4.4· 8 reviews
Average ratingGreat
4.4/ 5

Based on 8 reviews

550%
438%
313%
20%
10%
Ask AI

Ask Trustburn about Bukwang Pharmaceutical Co

Based on 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Dan Lovely
Reviews 1

I had a mixed experience with Bukwang Pharmaceutical Co. Although their products were effective, their customer service was disappointing. The representatives were unhelpful and impolite. However, their website was user-friendly and easy to navigate. Overall, I would rate them as average.

Kenneth Aragon
Reviews 1

I recently purchased some products from a pharmaceutical company's website. The products were of good quality and delivered on time. However, I was not satisfied with the overall customer service. The representatives were not responsive and lacked professionalism. Nonetheless, the products met my expectations.

Matheus Mendes
Reviews 1

The pharmaceutical company exceeded my expectations in terms of the quality of their products. The website was user-friendly, and I had no issues while ordering. Their customer service was exceptional, promptly addressing my queries and concerns. I highly recommend their products!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Bukwang Pharmaceutical Co

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a healthy financial status and stable track record that earned trust from its employees and shareholders. Bukwang’s operating profit is at the top of the rank in the industry, nearing 20% as of financial year 2014.
Bukwang’s armamentarium consists of more than 100 products in various therapeutic areas: liver disease treatments such as Levovir and Legalon, diabetic complication products such as Dexid and Thioctacid, CNS disorder drugs including Lonasen, Ixel and Orfil, and respiratory disease treatments such as Azeptin and Asima. Bukwang continues to grow its original drug business through consistent focus on new drug development.